Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2007 Oct 29;42(12):1125–1133. doi: 10.1002/ppul.20706

Atopic characteristics of wheezing children and responses to prednisolone

Tuomas Jartti 1,✉, Pasi Lehtinen 1, Timo Vanto 1, Tytti Vuorinen 2, Heikki Hiekkanen 3, Jaakko Hartiala 4, Mika J Mäkelä 5, Olli Ruuskanen 1
PMCID: PMC7167645  PMID: 17968992

Abstract

We wanted to test the hypothesis that the efficacy of systemic corticosteroid is associated with atopic characteristics in wheezing children.

A randomized controlled trial comparing oral prednisolone (2 mg/kg/day in 3 divided doses for 3 days) with placebo in hospitalized wheezing children (n = 266, median 1.6 years, range 3 months to 15.2 years) was conducted. In this post‐hoc analysis, we assessed the link between the efficacy of prednisolone and several atopic characteristics, such as atopy, aeroallergen sensitization, total IgE level, number of sensitizations, eczema, atopic eczema, blood or nasal eosinophils, exhaled nitric oxide, positive modified asthma predictive index/asthma, inhaled corticosteroid medication and parental asthma/allergy. Virology was studied comprehensively. Our primary endpoint was the time until ready for discharge, and the most important secondary endpoint was the occurrence of relapses during the following 2 months. For statistics, we used interaction analyses in uni‐ and multivariate regression models.

Overall, prednisolone did not decrease any of our predefined clinical endpoints. Neither was the efficacy of prednisolone associated with atopy. However, prednisolone significantly decreased the time until ready for discharge in children with positive modified asthma predictive index/asthma, inhaled corticosteroids, or rhinovirus infection and/or in children without azithromycin treatment. Prednisolone significantly decreased relapses in children with eczema, nasal eosinophilia and rhinovirus infection.

The multiple clinical, inflammatory and viral markers associating with the efficacy of prednisolone should be confirmed in prospective trials. It is important that corticosteroid intervention trials have strict design for these potentially confounding factors. Pediatr Pulmonol. 2007; 42:1125–1133. © 2007 Wiley‐Liss, Inc.

Keywords: prednisolone, child, wheezing, asthma, atopy, eosinophils, exhaled nitric oxide, rhinovirus, virus, macrolides

REFERENCES

  • 1. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332: 133–138. [DOI] [PubMed] [Google Scholar]
  • 2. Illi S, von Mutius E, Lau S, Niggemann B, Gruber C, Wahn U. Multicentre Allergy Study (MAS) group. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006; 368: 763–770. [DOI] [PubMed] [Google Scholar]
  • 3. Lemanske RF Jr, Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, Kirk CJ, Reisdorf E, Roberg KA, Anderson EL, Carlson‐Dakes KT, Adler KJ, Gilbertson‐White S, Pappas TE, Dasilva DF, Tisler CJ, Gern JE. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 2005; 116: 571–577. [DOI] [PubMed] [Google Scholar]
  • 4. Kotaniemi‐Syrjänen A, Vainionpää R, Reijonen TM, Waris M, Korhonen K, Korppi M. Rhinovirus‐induced wheezing in infancy—The first sign of childhood asthma? J Allergy Clin Immunol 2003; 111: 66–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, Sly PD. Early‐life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119: 1105–1110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Roosevelt G, Sheehan K, Grupp Phelan J, Tanz RR, Listernick R. Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet 1996; 348: 292–295. [DOI] [PubMed] [Google Scholar]
  • 7. De Boeck K, Van der Aa N, Van Lierde S, Corbeel L, Eeckels R. Respiratory syncytial virus bronchiolitis: a double‐blind dexamethasone efficacy study. J Pediatr 1997; 131: 919–921. [DOI] [PubMed] [Google Scholar]
  • 8. Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent‐initiated oral prednisolone for viral wheeze in children aged 1–5 years: randomized controlled trial. Lancet 2003; 362: 1433–1438. [DOI] [PubMed] [Google Scholar]
  • 9. Jartti T, Lehtinen P, Vanto T, Hartiala J, Vuorinen T, Mäkelä MJ, Ruuskanen O. Evaluation of the efficacy of prednisolone in early wheezing induced by rhinovirus or respiratory syncytial virus. Pediatr Infect Dis J 2006; 25: 482–488. [DOI] [PubMed] [Google Scholar]
  • 10. Jartti T, Lehtinen P, Vanto T, Vuorinen T, Hartiala J, Hiekkanen H, Malmberg P, Mäkelä MJ, Ruuskanen O. Efficacy of prednisolone in children hospitalized for recurrent wheezing. Pediatr Allergy Immunol 2007; 18: 326–334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Allander T, Jartti T, Gupta S, Niesters HG, Lehtinen P, Osterback R, Vuorinen T, Waris M, Bjerkner A, Tiveljung‐Lindell A, van den Hoogen BG, Hyypia T, Ruuskanen O. Human bocavirus and acute wheezing in children. Clin Infect Dis 2007; 44: 904–910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Lehtinen P, Ruohola A, Vanto T, Vuorinen T, Ruuskanen O, Jartti T. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol 2007; 119: 570–575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. National Asthma Education and Prevention Program Expert Panel Report 2 Guidelines for the Diagnosis and Management of Asthma. Update 1997; http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
  • 14. NAEPP Expert Panel Report , Guidelines for the Diagnosis and Management of Asthma—2007. http://www.nhlbi.nih.gov/guidelines/asthma/index.htm.
  • 15. Castro‐Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000; 162: 1403–1406. [DOI] [PubMed] [Google Scholar]
  • 16. Jartti T, Lehtinen P, Vuorinen T, Österback R, van den Hoogen B, Osterhaus AD, Ruuskanen O. Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis 2004; 10: 1095–1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM. Characterization of within‐subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005; 115: 233–242. [DOI] [PubMed] [Google Scholar]
  • 18. Farr BM, Gwaltney JM Jr, Hendley JO, Hayden FG, Naclerio RM, McBride T, Doyle WJ, Sorrentino JV, Riker DK, Proud D. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990; 162: 1173–1177. [DOI] [PubMed] [Google Scholar]
  • 19. Bisgaard H, Northman Hermansen M, Loland L, Brydensholt Halkjaer L, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. New Engl J Med 2006; 354: 1998–2005. [DOI] [PubMed] [Google Scholar]
  • 20. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, Bacharier LB, Lemanske RF Jr, Strunk RC, Allen DB, Bloomberg GR, Heldt G, Krawiec M, Larsen G, Liu AH, Chinchilli VM, Sorkness CA, Taussig LM, Martinez FD. Long‐term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354: 1985–1997. [DOI] [PubMed] [Google Scholar]
  • 21. Guilbert TW, Morgan WJ, Zeiger RS, Bacharier LB, Boehmer SJ, Krawiec M, Larsen G, Lemanske RF, Liu A, Mauger DT, Sorkness C, Szefler SJ, Strunk RC, Taussig LM, Martinez FD. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol 2004; 114: 1282–1287. [DOI] [PubMed] [Google Scholar]
  • 22. Malmberg LP, Pelkonen AS, Haahtela T, Turpeinen M. Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax 2003; 58: 494–499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Gustafson LM, Proud D, Hendley JO, Hayden FG, Gwaltney JM Jr. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996; 97: 1009–1014. [DOI] [PubMed] [Google Scholar]
  • 24. Grunberg K, Sharon RF, Sont JK, In 't Veen JC, Van Schadewijk WA, De Klerk EP, Dick CR, Van Krieken JH, Sterk PJ. Rhinovirus‐induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med 2001; 164: 1816–1822. [DOI] [PubMed] [Google Scholar]
  • 25. Martin RJ, Szefler SJ, King TS, Kraft M, Boushey HA, Chinchilli VM, Craig TJ, Dimango EA, Deykin A, Fahy JV, Israel E, Lazarus SC, Lemanske RF Jr, Leone FT, Pesola GR, Peters SP, Sorkness CA, Szwejbka LA, Wechsler ME. the National Heart, Lung, and Blood Institute's Asthma Clinical Research Center. for the National Heart, Lung, and Blood Institute's Asthma Clinical Research Center. The predicting response to inhaled corticosteroid efficacy (PRICE) trial. J Allergy Clin Immunol 2007; 119: 73–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Papadopoulos NG, Xepapadaki P, Mallia P, Brusselle G, Watelet JB, Xatzipsalti M, Foteinos G, van Drunen CM, Fokkens WJ, D'Ambrosio C, Bonini S, Bossios A, Lotval J, van Cauwenberge P, Holgate ST, Canonica GW, Szczeklik A, Rohde G, Kimpen J, Pitkaranta A, Makela M, Chanez P, Ring J, Johnston SL. Mechanisms of virus‐induced asthma exacerbations: state‐of‐the‐art. A GA2LEN and InterAirways document. Allergy 2007; 62: 457–470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Singh AM, Moore PE, Gern JE, Lemanske RF Jr, Hartert TV. Bronchiolitis to asthma: a review and call for studies of gene‐virus interactions in asthma causation. Am J Respir Crit Care Med 2007; 175: 108–119. [DOI] [PubMed] [Google Scholar]
  • 28. Lehtinen P, Jartti T, Virkki R, Vuorinen T, Leinonen M, Peltola V, Ruohola A, Ruuskanen O. Bacterial coinfections in children with viral wheezing. Eur J Clin Microbiol Infect Dis 2006; 25: 463–469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Borszcz PD, Befus D, Moqbel R, Sin DD, Adamko DJ, Man SF, Lacy P. Effects of clarithromycin on inflammatory cell mediator release and survival. Chemotherapy 2005; 51: 206–210. [DOI] [PubMed] [Google Scholar]
  • 30. Daenas C, Hatziefthimiou AA, Gourgoulianis KI, Molyvdas PA. Azithromycin has a direct relaxant effect on precontracted airway smooth muscle. Eur J Pharmacol 2006; 553: 280–287. [DOI] [PubMed] [Google Scholar]
  • 31. Richeldi L, Ferrara G, Fabbri LM, Lasserson TJ, Gibson PG. Macrolides for chronic asthma. Cochrane Database Syst Rev 2005; 4: CD002997. [DOI] [PubMed] [Google Scholar]

Articles from Pediatric Pulmonology are provided here courtesy of Wiley

RESOURCES